Literature DB >> 25649660

Validating hyperbilirubinemia and gut mucosal atrophy with a novel ultramobile ambulatory total parenteral nutrition piglet model.

Ajay K Jain1, Joy X Wen2, Sumit Arora2, Keith S Blomenkamp2, Jonathan Rodrigues2, Timothy A Blaufuss2, Victor Liou2, Douglas G Burrin3, John P Long2, Jeffery H Teckman2.   

Abstract

Total parenteral nutrition (TPN) provides all nutrition intravenously. Although TPN therapy has grown enormously, it causes significant complications, including gut and hepatic dysfunction. Current models use animal tethering which is unlike ambulatory human TPN delivery and is cost prohibitive. We hypothesize that using ultramobile infusion pumps, TPN can be delivered cost-effectively, resulting in classical gut and hepatic injury, and we thus aim to establish a new model system. Neonatal pigs (n=8) were implanted with jugular vein and duodenal catheters. Animals were fitted in dual-pocket jackets. An ultramobile ambulatory pump was placed in one pocket and connected to the jugular vein or duodenal catheter. Isocaloric TPN or swine formula was placed in the other pocket. Rigorous Wifi-based video and scheduled monitoring was performed. After 14days, the animals were euthanized. The mean (±SD) daily weight gain (in grams) for enteral-fed control (EN) vs TPN animals was 102.4±10.8 and 91.03±12.1 respectively (P<.05). Total parenteral nutrition resulted in significant conjugated bilirubin elevation and hepatomegaly. Mean (±SD) serum conjugated bilirubin (in μmol/L) was 1.5±0.7 for EN and 6.3±2.8 for TPN (P<.05). Marked gut atrophy was noted with TPN. The mean (±SD) gut weight as a percent of body weight was 4.30±0.26 for EN and 2.62±0.48 for TPN (P<.05). Surgical sites healed well. All animals remained completely mobile. We thus established that TPN can be successfully delivered using ultramobile pumps and believe that this remains the first such description of an ambulatory piglet TPN model system. In addition to cholestasis and gut atrophy, classical TPN-induced injury was documented.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Administration; Liver and gut disease; Neonates; Parenteral nutrition; Pediatrics

Mesh:

Year:  2014        PMID: 25649660     DOI: 10.1016/j.nutres.2014.12.004

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  10 in total

1.  No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.

Authors:  Gustavo Villalona; Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Thomas Ratchford; Matthew Westrich; Vindhya Kakarla; Shruthika Pochampally; William Phillips; Nicole Heafner; Niraja Korremla; Jose Greenspon; Miguel A Guzman; Ajay Kumar Jain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-04-27       Impact factor: 4.016

2.  Actively implementing enteral nutrition to reduce parenteral nutrition-associated liver disease.

Authors:  Shuifang Jin; Ronglin Jiang; Weibin Ma
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

3.  Developing a Novel Ambulatory Total Parenteral Nutrition-Dependent Short Bowel Syndrome Animal Model.

Authors:  Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Salim Munoz Abraham; Jose Greenspon; Gustavo A Villalona; Ajay Kumar Jain
Journal:  J Surg Res       Date:  2018-09-27       Impact factor: 2.192

Review 4.  Beyond lipids: Novel mechanisms for parenteral nutrition-associated liver disease.

Authors:  Brittany E Wichman; Jamie Nilson; Srinivas Govindan; Alan Chen; Aditya Jain; Varsha Arun; Juana Derdoy; Joseph Krebs; Ajay K Jain
Journal:  Nutr Clin Pract       Date:  2022-02-06       Impact factor: 3.080

5.  Carbamazepine mitigates parenteral nutrition-associated liver disease in a novel ambulatory piglet model.

Authors:  Eric Song; Aakash Nagarapu; Johan van Nispen; Austin Armstrong; Chandrashekhara Manithody; Vidul Murali; Marcus Voigt; Ashish Samaddar; Chelsea Hutchinson; Sonali Jain; Jeremy Roenker; Joseph Krebs; Ajay K Jain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2022-02-15       Impact factor: 3.896

6.  Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition.

Authors:  Ajay Kumar Jain; Abhineet Sharma; Sumit Arora; Keith Blomenkamp; Ik Chan Jun; Robert Luong; David John Westrich; Aayush Mittal; Paula M Buchanan; Miguel A Guzman; John Long; Brent A Neuschwander-Tetri; Jeffery Teckman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-08-20       Impact factor: 4.016

7.  Role of Bile Acids and Gut Microbiota in Parenteral Nutrition Associated Injury.

Authors:  Chandra Shekhara Manithody; Johan Van Nispen; Vidul Murali; Sonali Jain; Ashish Samaddar; Austin Armstrong; Ajay Jain
Journal:  J Hum Nutr (Carson City)       Date:  2020-03-02

8.  Impaired Gut-Systemic Signaling Drives Total Parenteral Nutrition-Associated Injury.

Authors:  Miguel Guzman; Chandrashekhara Manithody; Joseph Krebs; Christine Denton; Sherri Besmer; Pranjali Rajalakshmi; Sonali Jain; Gustavo Adolfo Villalona; Ajay Kumar Jain
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

9.  Lower systemic inflammation is associated with gut firmicutes dominance and reduced liver injury in a novel ambulatory model of parenteral nutrition.

Authors:  Ashish Samaddar; Johan van Nispen; Austin Armstrong; Eric Song; Marcus Voigt; Vidul Murali; Joseph Krebs; Chandra Manithody; Christine Denton; Aaron C Ericsson; Ajay Kumar Jain
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 10.  Role of the Gut⁻Liver Axis in Driving Parenteral Nutrition-Associated Injury.

Authors:  Christine Denton; Amber Price; Julie Friend; Chandrashekhara Manithody; Keith Blomenkamp; Matthew Westrich; Vindhya Kakarla; William Phillips; Joseph Krebs; Salim Abraham Munoz; Hector Osei; Ajay Kumar Jain
Journal:  Children (Basel)       Date:  2018-09-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.